This study identifies differences in COVID-19 related attitudes and risk perceptions among urban, rural, and suburban populations in the US using data from an online, nationwide survey collected during April-October 2020. In general, rural respondents were found to be less concerned by the pandemic and a lower proportion of rural respondents support staying at home and shutting down businesses. While only about half of rural respondents are concerned about getting severe reactions themselves from COVID-19 (compared to ~60% for urban and suburban respondents), all place types respondents are concerned about friends or family members getting severe reactions (~75%).
For cities, having a declining population usually means socio-economic and infrastructure challenges to accommodate the remaining population. Using population projections, we found that by 2100, close to half of the nearly 30,000 cities in the U.S. will face some sort of population decline, representing 12–23% of the population of these 30,000 cities and 27–44% of the populated area. The implications of this massive decline in population will bring unprecedented mobility and infrastructure challenges, possibly leading to disruptions in basic services like transit, clean water, electricity, and internet access. Simultaneously, increasing population trends in resource-intensive suburban and periurban cities will likely take away access to much needed resources in depopulating areas, further exacerbating their challenges. While immigration could play a vital role, resource distribution challenges will persist unless a paradigm shift happens away from growth-based planning alone.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.